Palisade Bio (PALI) EBIAT (2016 - 2025)
Historic EBIAT for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$2.9 million.
- Palisade Bio's EBIAT rose 1775.16% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.2 million, marking a year-over-year increase of 2018.49%. This contributed to the annual value of -$14.4 million for FY2024, which is 1738.21% down from last year.
- Latest data reveals that Palisade Bio reported EBIAT of -$2.9 million as of Q3 2025, which was up 1775.16% from -$2.8 million recorded in Q2 2025.
- Palisade Bio's EBIAT's 5-year high stood at $8.1 million during Q3 2021, with a 5-year trough of -$31.7 million in Q2 2021.
- In the last 5 years, Palisade Bio's EBIAT had a median value of -$3.4 million in 2023 and averaged -$4.3 million.
- Data for Palisade Bio's EBIAT shows a peak YoY increase of 53879.54% (in 2021) and a maximum YoY decrease of 161507.29% (in 2021) over the last 5 years.
- Palisade Bio's EBIAT (Quarter) stood at $8.1 million in 2021, then crashed by 146.0% to -$3.7 million in 2022, then rose by 20.13% to -$3.0 million in 2023, then decreased by 12.55% to -$3.3 million in 2024, then grew by 14.23% to -$2.9 million in 2025.
- Its last three reported values are -$2.9 million in Q3 2025, -$2.8 million for Q2 2025, and -$2.2 million during Q1 2025.